PTGX - Protagonist Therapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
84.24 1.8 (2.14%) 0.01 (0.01%) -0.05 (-0.06%) -0.01 (-0.01%) --- 1.8 (2.14%) --- ---

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.55
Diluted EPS:
-0.55
Basic P/E:
-156.4364
Diluted P/E:
-156.4364
RSI(14) 1m:
44.59
VWAP:
86.05
RVol:

Events

Period Kind Movement Occurred At

Related News